Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Falls and Its Consequences in Elderly People (PRECIOSA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02617303
Recruitment Status : Active, not recruiting
First Posted : November 30, 2015
Last Update Posted : September 4, 2019
Sponsor:
Information provided by (Responsible Party):
Jordi Gol i Gurina Foundation

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Falls are an important risk factor for fragility fractures. Both are associated with the ageing process and as they rise also increase the risk of mortality, disability and dependency. Interventions to prevent falls have been based on multifactorial approaches but the outcomes have shown little effectiveness. Lately, it is being recommended interventions which foster physical exercise incorporating it to daily life activities. The OTAGO exercise programme is based on easy physical exercises for older adults and has shown cost-effective outcomes for falls prevention and its consequences.

Condition or disease Intervention/treatment Phase
Accidental Falls Osteoporosis Procedure: OTAGO's exercises Procedure: COMMON PRACTICE Not Applicable

Detailed Description:
This is a randomized clinical trial carried out in primary care. The study's scope of activity will include four urban primary care centers. All selected patients with inclusion criteria will receive a geriatric assessment and other required medical treatment. Next, they will be allocated either to an intervention group or control group. The intervention group will be trained for three months according to the OTAGO exercise program (training phase). Followed by a loyalty phase during which they will be monitored quarterly for a year by their assessment team. The control group will be receive normal medical treatment. Falls and fractures will be monitored quarterly in both groups during 15 months.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 402 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effectiveness of an Intervention Through Physical Exercise for the Prevention of Falls and Its Consequences in Elderly People (75-89 Years) Performed in Primary Care: Study Protocol for a Randomized Controlled Trial
Study Start Date : September 2015
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : July 2020

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: OTAGO'S program arm
Patients meeting the inclusion criteria will be randomly assigned to the experimental group. They will receive OTAGO'S exercise program during three months, followed by adherence phase. Falls and fractures will be quarterly followed during 15 months.
 Procedure: OTAGO's exercises
The intervention is based on OTAGO's program, consisting of a set of aerobic exercises affecting gait, balance, stability and are adapted for older people to support them both in groups and individually. The program lasts 3 months and is followed by a loyalty phase to consolidate the exercise program. Falls and fractures will be monitored quarterly for 15 months.
Active Comparator: CONTROL GROUP
Patients meeting the inclusion criteria will be randomly assigned to the control group. Normal medical treatment will be provided by family physicians and nurses. Falls and fractures will be quarterly followed during 15 months.
 Procedure: COMMON PRACTICE
Normal medical treatment will be provided by family physicians and nurses.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Reduction of falls measured with a questionnaire from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on fall reduction in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured with a questionnaire at baseline and during follow-up.


Secondary Outcome Measures :
  1. Reduction of fracture measured with a questionnaire (location, causes and consequences) from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on fracture reduction in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured with a questionnaire (location, causes and consequences) at baseline and during follow-up.

  2. Reduction of fear to fall measured with Falls Efficacy Scale (FES) from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on reduction of fear to fall in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured with Falls Efficacy Scale (FES) at baseline and during follow-up.

  3. Parameters of physical frailty (strength) measured with switched test Timed Get Up and Go (TGUAG) from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on improvement of parameters of physical frailty (strength) in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured with switched test Timed Get Up and Go (TGUAG) at baseline and during follow-up.

  4. Parameters of physical frailty (balance) measured through Biodex Balance System ('stability index') from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on improvement of parameters of physical frailty (balance) in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured through Tinneti Scale and Biodex Balance System. Biodex Balance System provides valid, reliable and repeatable objective measures of a patient's ability to balance on stable and unstable surfaces. It provides visual biofeedback of a patient's ability to control their centre of gravity and their limits of stability. This test provides an objective 'stability index' that if higher than the predicted value indicates a strength, proprioception, and vestibular or visual impairment. Both monitoring at baseline and during follow-up.

  5. Parameters of physical frailty (motion) measured through "BTS G-WALK" from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on improvement of parameters of physical frailty (flexibility) in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured through "BTS G-WALK". It is a wireless laptop, its software allows to analyze basic parameters of motion. It will be monitoring at baseline and during follow-up.

  6. Parameters of physical frailty (endurance) measured with dynamometer from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on improvement of parameters of physical frailty (endurance) in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be tested as strength measured with dynamometer in leg and arm. It will be monitoring at baseline and during follow-up.

  7. Appointment at the surgery measured through questionnaire of number of appointment in the practice [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on reduction of appointment in the practice of primary and second care and hospital admission in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured through questionnaire of number of appointment in the practice in the previous year and during follow-up.

  8. Nursing Home admittance measured through questionnaire [ Time Frame: 15 months ]
    Evaluate the incidence of OTAGO's physical intervention program on reduction of inclusion rate in home care or institutionalization in elderly (75-89years). Starting training with phase guided by physiotherapist, followed by loyalty phase guided by regular nurse. It will be measured through questionnaire of home care and/or institutionalization in the previous year and during follow-up.

  9. Drug reduction measured through questionnaire of kind of drug from April 2016 to June 2017. [ Time Frame: 15 months ]
    Evaluate the effect of drug reduction in the intervention of disprescription performed in the cohort by the usual care team in elderly (75-89 years). It will be measured through questionnaire of kind of drug, if there are any removed drug, and number and kind of drug removed to the end. Monitoring at baseline and during follow-up.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years to 89 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients ≥ 75 to 89 years at baseline assigned to Primary Care Team and living in the community
  • Ranking the Folstein Mini Mental State Examination test
  • Expectation of permanence in the area at least 18 months.
  • Agree to participate in the study by informed consent, after reading the patient information sheet.

Exclusion Criteria:

  • Current participation in another trial or institutional program of guided physical activity.
  • Patients with who have had a hip and/or knee operation or major injury or any other intervention in the last 6 months.
  • Patients with who are unable to follow an aerobic physical activity program. Patients using assisted mobility devices are not excluded.
  • Patients in Home Care Programs or Nursing Homes at baseline or during the training phase.
  • Terminal or severe cancer cases.
  • Patients disabled prior to or during the study period.
  • Have not been visited in reference's Health Center in the last two years (displacement / transfer
  • Very advanced dementia that not allows to follow the instructions in the exercise program and nurse's instructions. In case of a caregiver who assume the realization of exercise program and the following of tips, it may be included.
  • Displaced, will temporarily shifted (>2months/year) o will definitively shifted patients of Health Center.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02617303


Locations
Layout table for location information
Spain
CAP Barberà del Vallès
Barberà del Vallès, Barcelona, Spain, 08210
CAP Canaletes
Cerdanyola del Vallès, Barcelona, Spain, 08290
CAP Serraparera
Cerdanyola del Vallès, Barcelona, Spain, 08290
CAP Creu Alta
Sabadell, Barcelona, Spain, 08208
CAP Badia del Vallés
Barcelona, Spain, 08214
CAP Castellar
Castellar del Vallès, Spain, 08211
CAP La Llagosta
La Llagosta, Spain, 08120
Cap Centre
Sabadell, Spain, 08201
Cap Can Rull
Sabadell, Spain, 08206
CAP Ca N'Oriach
Sabadell, Spain, 08207
CAP Sud
Sabadell, Spain
Sponsors and Collaborators
Jordi Gol i Gurina Foundation
Investigators
Layout table for investigator information
Principal Investigator: Rafael Azagra, PhD Insitut Català de la Salut, Universitat Autònoma de Barcelona
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for additonal information
Responsible Party: Jordi Gol i Gurina Foundation
ClinicalTrials.gov Identifier: NCT02617303    
Other Study ID Numbers: P14/099
First Posted: November 30, 2015    Key Record Dates
Last Update Posted: September 4, 2019
Last Verified: September 2015
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Keywords provided by Jordi Gol i Gurina Foundation:
elderly
accidental falls
osteoporosis
fractures
 Primary Care
Randomized clinical trial
Otago exercise programme
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases